Thu, August 22, 2019
Wed, August 21, 2019
Tue, August 20, 2019
Mon, August 19, 2019
Fri, August 16, 2019

Brian Skorney Maintained (SRPT) at Buy with Decreased Target to $181 on, Aug 20th, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-181-on-aug-20th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Brian Skorney of Baird, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $202 to $181 on, Aug 20th, 2019.

Brian has made no other calls on SRPT in the last 4 months.



There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 0 agree with Brian's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Brian


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $220 on, Tuesday, July 9th, 2019
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $220 on, Monday, July 1st, 2019
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $190 on, Thursday, May 16th, 2019